Evaluation of treatments for sore throat associated with acute pharyngitis and/or viral tonsillitis

Sore throats that have developed recently-within the last 3 days-are primarily caused by an infectious inflammation of the tonsils (tonsillitis) and/or the entire oropharynx (pharyngitis). They may be accompanied by a runny nose or cough as part of a nasopharyngitis. This inflammation is generally caused by infectious agents (bacterial or viral) that often appear in the fall and affect people of all ages. The majority of acute tonsillitis cases are viral and affect approximately 9 million people in France each year. Treatment for viral causes is symptomatic. The use of medical devices in the form of topical applications, such as throat sprays, which target the surface of the throat and mechanically dislodge and drain contaminants while acting as a cleansing solution, can help patients by alleviating symptoms and improving quality of life. The purpose of this study is to confirm, in a post-market setting, the tolerability of four medical devices based on real-world data. These products have already been the subject of two publications, with a third currently under review. Their tolerability has therefore already been evaluated previously. However, changes to the European Medical Device Regulation (2017/745) have led G-MED to request the conduct of this post-market study.